title: Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
authors.affiliation: Linköping University, Linköping Sweden johnny.ludvigsson@liu.se.
authors.forename: Johnny
authors.initials: J
authors.lastname: Ludvigsson
authors.affiliation: Linköping University, Linköping Sweden johnny.ludvigsson@liu.se.
authors.forename: Jeanette
authors.initials: J
authors.lastname: Wahlberg
authors.affiliation: Linköping University, Linköping Sweden johnny.ludvigsson@liu.se.
authors.forename: Rosaura
authors.initials: R
authors.lastname: Casas
mesh_terms: D019540:Area Under Curve; D001324:Autoantigens / Q000008:administration & dosage* / Q000009:adverse effects; D002096:C-Peptide / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005968:Glutamate Decarboxylase / Q000008:administration & dosage* / Q000009:adverse effects; D065386:Historically Controlled Study; D006801:Humans; D007272:Injections, Intralymphatic / Q000009:adverse effects; D010865:Pilot Projects; D014807:Vitamin D / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D001324:Autoantigens; D002096:C-Peptide; D014815:Vitamins; D014807:Vitamin D; D005968:Glutamate Decarboxylase